Financing channel feed – Endpoints News

Financing channel feed

Former NCI director teams up with serial entrepreneur for $70M VC fund targeting 'super-early' science

5 months ago

Exclusive: Synapticure raises $25M for its approach to virtual neurodegenerative disease care

5 months ago

Atlas Venture targets $450M for 14th biotech fund, the same size as its 2022 raise

5 months ago

Metsera raises $215M for studies of GLP-1 and amylin obesity drugs

5 months ago

TRexBio raises $84M to take in-house immune program into the clinic

5 months ago

Exclusive: GV-backed Medicaid startup Diverge Health raises $52M

6 months ago

Alentis nabs $181M to broaden Claudin's scope in ADCs

6 months ago

Maze's ALS spinout Trace Neuroscience raises $101M for ALS and neuro work

6 months ago

Pfizer to invest $1B in China over next five years — reports

6 months ago

Stephen Squinto's JPM life sciences team is raising a new fund for later-stage companies

6 months ago

Exclusive: Blood stem cell therapy maker Garuda gets new CEO, adds $47M

6 months ago

Evommune raises $115M for I&I pipeline and prepares for Phase 2 results

6 months ago

Blue Earth Therapeutics snags $76M for both alpha and beta radiotherapies

6 months ago

A startup backed by Nobel winner David Baker takes an AI twist on antibodies

6 months ago

Axonis snags $115M to test oral drugs for epilepsy and neuropathic pain

6 months ago

Pathos AI nabs $62M Series C as it hunts for more Phase 1 drugs with AI

6 months ago

Synaffix, industry's ADC partner of choice, spins out a startup pipeline

6 months ago

Septerna bags $288M upsized IPO for GPCR drugs

6 months ago

Sanofi backs fibrosis biotech Agomab as it raises $89M Series D

6 months ago

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

6 months ago

Radiopharma startups stay hot as Alpha-9 bags $175M Series C

6 months ago

Life sciences investor Dimension seeks to raise $500M second fund

6 months ago

Houston startup March Biosciences raises $28M to get CAR-T into Phase 2

6 months ago

Be Bio raises $82M to fund work on B cell therapy in hemophilia B

6 months ago

First page Previous page 4 5 678 9 10 Next page Last page